Science Explorer Back to mapMap
Discussion
Researcher · Instituto Alexander Fleming · Argentina

Julio César Sánchez Ávalos

Julio César Sánchez Ávalos publishes mostly in Hematology, Oncology and Immunology, on topics such as Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research and Lymphoma Diagnosis and Treatment.

OpenAlex
World rank
#7,026,549
of 7,710,434 ranked researchers
Rank in Argentina
#32,094
of 38,473
Works
57
Citations
262
Citations per work
4.6
h-index
10
i10-index 14Top 60% in Hematology
Julio César Sánchez Ávalos

What does Julio César Sánchez Ávalos research?

Julio César Sánchez Ávalos's work is mostly in Medicine (56%), Immunology and Microbiology (9%).

Health Sciences: 32 works · 55.9% of their workMedicine: 32 works · 55.9% of their workHematology: 17 works · 29.7% of their workOncology: 5 works · 8.5% of their workGenetics: 4 works · 7.6% of their workPathology and Forensic Medicine: 3 works · 5.9% of their workPulmonary and Respiratory Medicine: 2 works · 4.2% of their workEverything else: 20 works · 35.6% of their workLife Sciences: 5 works · 8.5% of their workImmunology and Microbiology: 5 works · 8.5% of their workImmunology: 5 works · 8.5% of their workTHEIR WORKJulio CésarSánchez Ávalos57works
Life Sciences9%Health Sciences56%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3255.9%
  2. Everything else2035.6%
    1. Immunology and Microbiology58.5%
  1. 1Hematology30% of their works
  2. 2Oncology8% of their works
  3. 3Immunology8% of their works
  4. 4Genetics8% of their works
  5. 5Pathology and Forensic Medicine6% of their works
  6. 6Pulmonary and Respiratory Medicine4% of their works

Research topics

Which keywords describe Julio César Sánchez Ávalos's research?

The keywords of their largest research topics: Prognostic Factors, BCR-ABL, Imatinib, Rituximab, Hematopoietic Stem Cells, Lymphoma, Acute Myeloid Leukemia and AML.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Prognostic Factors142 topics
  2. BCR-ABL131 topic
  3. Imatinib131 topic
  4. Rituximab132 topics
  5. Hematopoietic Stem Cells112 topics
  6. Lymphoma112 topics
  7. AML81 topic
  8. Acute Myeloid Leukemia81 topic
  9. Classification71 topic
  10. Molecular Profiling71 topic
  11. Chronic Lymphocytic Leukemia61 topic
  12. Genomic Aberrations61 topic
  13. Alloimmunization51 topic
  14. Blood Groups51 topic
  15. CAR T Cells41 topic
  16. Chimeric Antigen Receptor41 topic
  17. NK Cell Recognition41 topic
  18. Natural Killer Cells41 topic
  19. Genetic Mutations31 topic
  20. Neutropenia31 topic

Where does Julio César Sánchez Ávalos work?

Julio César Sánchez Ávalos's main affiliation in the publication record is Instituto Alexander Fleming, Argentina.

How many publications and citations does Julio César Sánchez Ávalos have?

OpenAlex counts 57 works and 262 citations for Julio César Sánchez Ávalos, an h-index of 10, ranking #7,026,549 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Julio César Sánchez Ávalos. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.